78
Participants
Start Date
February 28, 2022
Primary Completion Date
November 1, 2023
Study Completion Date
December 1, 2024
Regular care with additionally administration of questionnaires
"Patients receiving regular care. In addition, validated questionnaires are administered at two measurement points:~1. after the multidisciplinary consultation, a baseline questionnaire\*, the decision conflict scale and the EQ-5D-5L questionnaire are administered by phone.~2. 1 month after completion of the treatment program (care pathway) the EQ-5D-5L, the BaSQoL and the EORTC IN-PATSAT32 questionnaires will be administered by phone.~Completing the questionnaires takes about 30 minutes each time.~\*Baseline questionnaire: gender, age, marital status, education level, World Health Organization (WHO) performance status, presence of informal care, stage and treatment of cSCC, history of skin cancer, presence of current other skin cancer, and average travel time to hospital."
Radboud UMC, Nijmegen
Maastricht University Medical Center +, Maastricht
Maastricht University Medical Center
OTHER